-
Hypertension is one of the most common conditions that primary care physicians face on a daily basis in the office. Control of hypertension is one of the most important therapeutic actions that the physician can do to prevent the development of serious complications in his or her patients.
-
The JUPITER trial causes a stir; ACP practice guideline for antidepressant use; testosterone for low libido; continued shortage of Hib vaccine; FDA Actions.
-
Leaders of the American Diabetes Association (ADA) joined with leaders of the European Association for the Study of Diabetes to reconsider the treatment strategy for patients with Type 2 diabetes.
-
The available results from three ezetimibe/simvastatin trials did not provide credible evidence of any adverse effects of ezetimibe on the rate of cancer association with ezetimibe administration at the present time.
-
Colesevelam is a bile-sequestering agent approved in 2000 for the treatment of hypercholesterolemia. It has recently been shown to be effective as add-on therapy for Type 2 diabetics.
-
5-α reductase inhibitors and hip fracture in men; the effects of drug-reimbursement policy on outcomes; new guidelines for type 2 diabetes; beta-blocker-associated brady-cardia is linked to CVD events; FDA Updates.
-
Women who had low serum 25(OH) vitamin D concentrations were observed to have a higher hip fracture risk independent of other factors.
-
Topical agents, both as monotherapy and in combination, have shown efficacy in management of acne. Benzoyl peroxide (BPO) is one of the most commonly used agents, but despite excellent efficacy, the side effects of skin dryness, burning, erythema, and peeling are sometimes limiting effects of treatment.
-
The ECG shown was obtained from a 60-year-old man who was seen in the office. How would you interpret this tracing if you did not have more information? Is there cause for potential concern?
-
Hereditary ovarian cancer syndromes are uncommon, but are most often represented by mutation in BRCA1/2.
